Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerrington Powell

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Investigation|July 17, 2022
Common misconceptions of randomized controlled trials in oncologyKerrington Powell, Vinay Prasad
European Urology Focus|April 7, 2021
Old-fashioned Intelligence Will Always Be Needed in MedicineKerrington Powell, Vinay Prasad
Translational Oncology|August 22, 2021
Concerning FDA approval of trilaciclib (Cosela) in extensive-stage small-cell lung cancerKerrington Powell, V Prasad
Translational Oncology|September 5, 2022
The AGILE trial of ivosidenib plus azacitidine versus azacitidine alone: How many limitations is too many?Anjali Bhatt, Kerrington Powell, Vinay Prasad
Trials|December 23, 2022
A novel trial methodology to test interventions with very large effect sizes: the case of dostarlimab in mismatch repair-deficient, locally advanced rectal cancerKerrington Powell, Timothée Olivier, Vinay Prasad
European Urology|September 12, 2022
Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION TrialTimothée Olivier, Kerrington Powell, Vinay Prasad
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 24, 2022
How Often do Medical Specialties Question the Practices that They Perform? An Empirical, Cross-Sectional Analysis of the Published LiteratureAlyson Haslam, Kerrington Powell, Vinay Prasad
European Urology|September 24, 2022
Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised RestraintKerrington Powell, Michael C Burns, Vinay Prasad
Journal of Cancer Policy|November 17, 2022
Financial conflicts of interest of OncoAlert: An informal oncology professional networkKerrington Powell, Akash Kakkilaya, Alyson Haslam, et al.
Journal of Cancer Policy|May 13, 2022
Characteristics of oncology podcasts: Attitudes, speakers, conflictsEmma Greenstreet Akman, Kerrington Powell, Alyson Haslam, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Investigation|July 17, 2022
Common misconceptions of randomized controlled trials in oncologyKerrington Powell, Vinay Prasad
European Urology Focus|April 7, 2021
Old-fashioned Intelligence Will Always Be Needed in MedicineKerrington Powell, Vinay Prasad
Translational Oncology|August 22, 2021
Concerning FDA approval of trilaciclib (Cosela) in extensive-stage small-cell lung cancerKerrington Powell, V Prasad
Translational Oncology|September 5, 2022
The AGILE trial of ivosidenib plus azacitidine versus azacitidine alone: How many limitations is too many?Anjali Bhatt, Kerrington Powell, Vinay Prasad
Trials|December 23, 2022
A novel trial methodology to test interventions with very large effect sizes: the case of dostarlimab in mismatch repair-deficient, locally advanced rectal cancerKerrington Powell, Timothée Olivier, Vinay Prasad
European Urology|September 12, 2022
Lutetium-177-PSMA-617 in Metastatic Castration-resistant Prostate Cancer: Limitations of the VISION TrialTimothée Olivier, Kerrington Powell, Vinay Prasad
Inquiry : a Journal of Medical Care Organization, Provision and Financing|March 24, 2022
How Often do Medical Specialties Question the Practices that They Perform? An Empirical, Cross-Sectional Analysis of the Published LiteratureAlyson Haslam, Kerrington Powell, Vinay Prasad
European Urology|September 24, 2022
Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised RestraintKerrington Powell, Michael C Burns, Vinay Prasad
Journal of Cancer Policy|November 17, 2022
Financial conflicts of interest of OncoAlert: An informal oncology professional networkKerrington Powell, Akash Kakkilaya, Alyson Haslam, et al.
Journal of Cancer Policy|May 13, 2022
Characteristics of oncology podcasts: Attitudes, speakers, conflictsEmma Greenstreet Akman, Kerrington Powell, Alyson Haslam, et al.
Pageof 2